Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Receivables - Other: 2018-2019

Historic Receivables - Other for DiaMedica Therapeutics (DMAC) over the last 1 years, with Sep 2019 value amounting to $600,000.

  • DiaMedica Therapeutics' Receivables - Other was N/A to $600,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $600,000, marking a year-over-year change of. This contributed to the annual value of $622,000 for FY2018, which is N/A change from last year.
  • Per DiaMedica Therapeutics' latest filing, its Receivables - Other stood at $600,000 for Q3 2019, which was down 41.29% from $1.0 million recorded in Q2 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Receivables - Other peaked at $1.0 million during Q2 2019, and registered a low of $600,000 during Q3 2019.
  • Over the past 2 years, DiaMedica Therapeutics' median Receivables - Other value was $709,000 (recorded in 2018), while the average stood at $760,000.